TURKISH NEUROSURGERY, vol.29, no.4, pp.570-575, 2019 (Journal Indexed in SCI)
AIM: To assess the distribution of genetic polymorphisms of killer cell immunoglobulin-like receptors (KIRs) to predict the clinical course of glioblastoma, report on the genetic mechanisms, and provide guidance on potential therapeutic methods.